Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

The Diagnostic Emergency: Identifying the Ameba

At a Glance

Diagnosing Primary Amebic Meningoencephalitis (PAM) is a medical emergency. If a patient with meningitis symptoms has a high white blood cell count but a negative bacterial test after freshwater exposure, doctors must urgently perform a warm CSF wet mount or PCR test to check for amebae.

When a patient shows signs of meningitis, every minute is vital. For Primary Amebic Meningoencephalitis (PAM), the diagnostic process is a race. Because the disease is so rare and so fast, doctors must look for “red flags” that point away from common bacteria and toward the Naegleria fowleri ameba.

The “Gram-Stain Negative” Red Flag

When a patient has symptoms of meningitis, the first step is often a lumbar puncture (spinal tap) to collect cerebrospinal fluid (CSF). The lab then performs a Gram stain, a quick test to see if bacteria are present [1][2].

In a typical case of PAM, two conflicting results appear:

  1. Neutrophilic Pleocytosis: The CSF shows a very high number of white blood cells (neutrophils), which usually means a severe infection is present [3][4].
  2. Gram-Stain Negative: Despite the high white cell count, the Gram stain shows no bacteria [1][5].

This combination is a major red flag [6]. If the patient has a history of freshwater exposure and the Gram stain is negative but the white cell count is high, the medical team must immediately pivot to testing for amebae [1][7].

The Definitive Tests

There are three main ways to definitively identify the ameba. The first is a manual check, while the others use advanced technology to find the ameba’s DNA.

1. The CSF Wet Mount (The Fastest Method)

The most rapid way to diagnose PAM is to look at a fresh, warm, uncentrifuged sample of CSF under a microscope [2][1].

  • What they look for: Doctors are searching for motile trophozoites—the active, moving stage of the ameba [2][8].
  • Why it’s tricky: The ameba looks very similar to the patient’s own white blood cells [1]. The key difference is their movement: amebae move in a slow, crawling “amoeboid” fashion using blunt projections called pseudopodia [9][7].
  • Temperature Matters: If the CSF is refrigerated or frozen, the amebae will stop moving or die, making them almost impossible to find [3][10].

2. PCR (Polymerase Chain Reaction)

A PCR test is used to detect the specific DNA of Naegleria fowleri [11][12]. This test is highly accurate and is considered the “gold standard” for confirmation [3]. Because many hospital labs do not have this specific test on hand, samples are often sent to the CDC or specialized state labs for rapid processing [13][14].

3. mNGS (Metagenomic Next-Generation Sequencing)

mNGS is a cutting-edge technology that can scan a sample for the DNA of thousands of different pathogens—bacteria, viruses, and parasites—all at once [15]. It is especially useful when the cause of an infection is a mystery or when standard tests are coming back negative despite the patient’s decline [16].

A Race Against Time

Current CDC guidelines emphasize that treatment should not wait for these test results if suspicion is high [17][6]. If the medical team highly suspects PAM, they are encouraged to contact the CDC Emergency Operations Center to coordinate rapid testing and begin specialized multi-drug treatment immediately [13]. Importantly, even if an initial PCR or mNGS test comes back negative or is pending, treatment should not be halted if the clinical suspicion remains extremely high, as false negatives can occur depending on the sample quality.

Common questions in this guide

Why is a "Gram-stain negative" result important if meningitis is suspected?
If cerebrospinal fluid shows a high white blood cell count but a negative Gram stain, it means bacteria are not the cause. If the patient has a history of freshwater exposure, this combination is a major red flag that doctors should immediately test for an ameba like Naegleria fowleri.
What is a CSF wet mount test for Naegleria fowleri?
A CSF wet mount involves examining fresh, warm, uncentrifuged spinal fluid under a microscope to look for moving amebae. It is the fastest way to diagnose Primary Amebic Meningoencephalitis, but the sample must not be refrigerated.
Why shouldn't a spinal fluid sample be refrigerated if PAM is suspected?
If cerebrospinal fluid is refrigerated or frozen, the amebae will stop moving and die. This makes them almost impossible to distinguish from normal white blood cells under a microscope, which can delay a life-saving diagnosis.
What role does PCR testing play in diagnosing PAM?
A PCR test looks for the specific DNA of Naegleria fowleri and is considered the gold standard for confirming the infection. Because it is highly specialized, samples are often sent to the CDC or specialized state labs for rapid processing.
Should we wait for PCR test results before starting treatment for PAM?
No, treatment should not wait. Because PAM progresses so rapidly, current guidelines emphasize that specialized multi-drug treatment should begin immediately if clinical suspicion is high, even while PCR or other confirmatory test results are still pending.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.If the Gram stain was negative but the white blood cell count is high, why are we waiting for cultures instead of performing a fresh CSF wet mount?
  2. 2.Was the CSF sample used for the wet mount kept at room temperature (not refrigerated) to ensure any amebae would stay moving and visible?
  3. 3.Has the medical team called the CDC Emergency Operations Center for a consultation on rapid PCR testing?
  4. 4.Could we order metagenomic next-generation sequencing (mNGS) to quickly identify any non-bacterial pathogens in the spinal fluid?
  5. 5.Is there a pathologist on-site who is specifically trained to distinguish Naegleria fowleri from white blood cells?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Death From Primary Amebic Meningoencephalitis After Recreational Water Exposure During Recent Travel to India-Santa Clara County, California, 2020.

    Harris GR, Karmarkar EN, Quenelle R, et al.

    Open forum infectious diseases 2021; (8(8)):ofab322 doi:10.1093/ofid/ofab322.

    PMID: 34395708
  2. 2

    Challenges and Strategies in Managing Naegleria fowleri-Associated Primary Amoebic Meningoencephalitis in Pakistan: A Case Report.

    Zaman M, Fida T, Haris HM, et al.

    Acta parasitologica 2025; (70(4)):150 doi:10.1007/s11686-025-01091-2.

    PMID: 40622499
  3. 3

    The Brief Case: A Case of Primary Amebic Meningoencephalitis (PAM) after Exposure at a Splash Pad.

    Eger L, Pence MA

    Journal of clinical microbiology 2023; (61(7)):e0126922 doi:10.1128/jcm.01269-22.

    PMID: 37470480
  4. 4

    Survival of primary amebic meningoencephalitis by Naegleria fowleri: First reported case from Tamil Nadu, South India.

    Perumalsamy V, Sundaramoorthy R, Ganesan V, Geni VG

    Tropical parasitology 2020; (10(2)):150-152 doi:10.4103/tp.TP_34_19.

    PMID: 33747885
  5. 5

    Genotyping and Molecular Identification of Acanthamoeba Genotype T4 and Naegleria fowleri from Cerebrospinal Fluid Samples of Patients in Turkey: Is it the Pathogens of Unknown Causes of Death?

    Aykur M, Dirim Erdogan D, Selvi Gunel N, et al.

    Acta parasitologica 2022; (67(3)):1372-1383 doi:10.1007/s11686-022-00597-3.

    PMID: 35864411
  6. 6

    Primary amoebic meningoencephalitis in children- report of two cases from South India.

    Joseph RB, Rauf A, Chettali AM, et al.

    Tropical doctor 2022; (52(4)):553-555 doi:10.1177/00494755221097046.

    PMID: 35880290
  7. 7

    Amebic infections of the central nervous system.

    Berger JR

    Journal of neurovirology 2022; (28(4-6)):467-472 doi:10.1007/s13365-022-01096-x.

    PMID: 36098909
  8. 8

    Central nervous system infections caused by pathogenic free-living amoebae: An Indian perspective.

    Raju R, Khurana S, Mahadevan A, John DV

    Tropical biomedicine 2022; (39(2)):265-280 doi:10.47665/tb.39.2.017.

    PMID: 35838101
  9. 9

    Identification and molecular typing of Naegleria fowleri from a patient with primary amebic meningoencephalitis in China.

    Zhang LL, Wu M, Hu BC, et al.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2018; (72()):28-33 doi:10.1016/j.ijid.2018.05.001.

    PMID: 29751112
  10. 10

    Laboratory Diagnosis of Primary Amoebic Meningoencephalitis.

    Rojo JU, Rajendran R, Salazar JH

    Laboratory medicine 2023; (54(5)):e124-e132 doi:10.1093/labmed/lmac158.

    PMID: 36638160
  11. 11

    Case Series of Naegleria fowleri Primary Ameobic Meningoencephalitis from Karachi, Pakistan.

    Ghanchi NK, Jamil B, Khan E, et al.

    The American journal of tropical medicine and hygiene 2017; (97(5)):1600-1602 doi:10.4269/ajtmh.17-0110.

    PMID: 29016297
  12. 12

    Noninvasive diagnostic biomarkers, genomic profiling, and advanced microscopic imaging in the early detection and characterization of Naegleria fowleri infections leading to primary amebic meningoencephalitis (PAM).

    Shaukat A, Khaliq N, Riaz R, et al.

    Annals of medicine and surgery (2012) 2024; (86(4)):2032-2048 doi:10.1097/MS9.0000000000001843.

    PMID: 38576920
  13. 13

    Advancing the understanding of Naegleria fowleri: Global epidemiology, phylogenetic analysis, and strategies to combat a deadly pathogen.

    Alanazi A, Younas S, Ejaz H, et al.

    Journal of infection and public health 2025; (18(4)):102690 doi:10.1016/j.jiph.2025.102690.

    PMID: 39913985
  14. 14

    A case report: primary amoebic meningoencephalitis in a young Zambian adult.

    Chomba M, Mucheleng'anga LA, Fwoloshi S, et al.

    BMC infectious diseases 2017; (17(1)):532 doi:10.1186/s12879-017-2638-8.

    PMID: 28764655
  15. 15

    A pediatric case of primary amoebic meningoencephalitis due to Naegleria fowleri diagnosed by next-generation sequencing of cerebrospinal fluid and blood samples.

    Huang S, Liang X, Han Y, et al.

    BMC infectious diseases 2021; (21(1)):1251 doi:10.1186/s12879-021-06932-9.

    PMID: 34906097
  16. 16

    A case of Naegleria fowleri related primary amoebic meningoencephalitis in China diagnosed by next-generation sequencing.

    Wang Q, Li J, Ji J, et al.

    BMC infectious diseases 2018; (18(1)):349 doi:10.1186/s12879-018-3261-z.

    PMID: 30055569
  17. 17

    Killer amoebas: Primary amoebic meningoencephalitis in a changing climate.

    Cooper AM, Aouthmany S, Shah K, Rega PP

    JAAPA : official journal of the American Academy of Physician Assistants 2019; (32(6)):30-35 doi:10.1097/01.JAA.0000558238.99250.4a.

    PMID: 31136398

This page explains diagnostic testing for Primary Amebic Meningoencephalitis (PAM) for educational purposes. Suspected PAM is a medical emergency requiring immediate evaluation by healthcare professionals and the CDC.

Get notified when new evidence is published on Primary amebic meningoencephalitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.